At a glance
ClinicalIndex Comparison RecordN/ACompleted· 89 enrolled
Drug / intervention
Postoperative cognitive dysfunctionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
S100B Protein as Predictor of Cognitive Dysfunction After Robot-assisted Radical Prostatectomy: A Prospective Observational Study
In Brief
An observational study evaluating Postoperative cognitive dysfunction for Postoperative Cognitive Dysfunction. Completed, enrolled 89 participants across 1 site.
Detailed Summary
Primary aim of this study is to evaluate the association between postoperative cognitive dysfunction and increased serum levels of S100B protein after robot-assisted laparoscopic radical prostatectomy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Cognitive Dysfunction
CountriesTurkey (Türkiye)
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 2017
Enrollment StartFeb 2017
Primary CompletionNov 2017
Study CompletionFeb 2018
TodayJul 2026
First PostedJan 12, 2017
Enrollment StartFeb 14, 2017
Primary CompletionNov 24, 2017
Study CompletionFeb 14, 2018
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 9.5 years ago
Interventions
Postoperative cognitive dysfunctionother
Neuropsychological tests of all patients will conduct on the one day prior to surgery, the 7th day after surgery, and the 3rd month after surgery